In vivo evaluation of a phosphorylcholine coated cardiopulmonary bypass circuit

Journal of Extra-Corporeal Technology

Volumn 31, Issue 2, 1999, Pages 62-66

  De Somer, F ^a,b   Van Belleghem, Y ^a   Foubert, L ^a   Francois K ^a   Dubrulle, F ^a   De Wolf, D ^a   Van Nooten, G ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Blood compatibility; Cardiopulmonary bypass; Complement; Oxygenator; Phosphorylcholine; Platelet activation

Indexed keywords

PHOSPHORYLCHOLINE; PROSTAGLANDIN E2; THROMBOCYTE FACTOR 4; THROMBOXANE B2;

ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; BLOOD COMPATIBILITY; CARBON DIOXIDE TRANSPORT; CARDIOPULMONARY BYPASS; GAS DIFFUSION; MALE; NONHUMAN; OXYGEN TRANSPORT; OXYGENATOR; THROMBOCYTE ACTIVATION;

EID: 0032723938     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Yianni YP. Biocompatible surfaces based upon biomembrane mimicry. In Quinn PJ, Cherry RI (eds). Structural and Dynamic Properties of Lipids and Membranes. Portland: Press Research Monograph; 1992; 187-216.
2. Campbell EJ, O'Byrne V, Stratford PW, Quirk J, Vick TA, Wiles MC, Yianni YP. Biocompatible surfaces using methacryloylphosphorylcholine laurylmethacrylate copolymer. ASAIO. 1994;40:853-857.
3. Yu J, Lamba NMK, Courtney JM, et al. Polymeric biomaterials: influence of phosphorylcholine polar groups on protein adsorption and complement activation. Int J Art Org. 1994;17:499-504.
4. Hunter S, Angelini GD. Phosphorylcholine coated chest tubes improve drainage after open heart surgery. Ann Thorac Surg. 1993;56:1139-1342.
5. Nordrehaug JE, Chronos NAF, Sigwart U. A biocompatible coating applied to metallic stents (abstract). J Am Coll Cardiol. 1994;5A.
6. Edmunds LH Jr. Cardiopulmonary bypass and blood. In Pifarré R. (ed.) Blood conservation with aprotinin. Philadelphia: Hanley & Belfus Inc.; 1995; 45-67.
7. Hatori N, Yoshizu H, Haga Y, Kusama Y, Takeshima S, Segawa D, Tanaka S. Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass. Art Org. 1994;18:904-910.
8. Ashraf S, Tian Y, Cowan D, Entress A, Martin PG, Watterson KG. Release of proinflamatory cytokines during pediatric cardiopulmonary bypass: Heparin-bonded versus nonbonded oxygenators. Ann Thorac Surg. 1997; 64:1790-1794.
9. DeFife KM, Yun JK, Azeez A, Stack S, Ishihara K, Nakabayashi N, Colton E, Anderson JM. Adhesion and cytokine production by monocytes on poly (2-methacryloyloxyethyl phosphorylcholine-co-alkyl methacrylate)-coated polymers. J Biomed Mater Res. 1995;29:431-439.
10. Butterworth JF, Utley JR, Swain JA. Neuroendocrine and electrolyte responses to cardiopulmonary bypass. In Gravlee GP, Davis RF, Utley JR (eds). Cardiopulmonary Bypass. Principles and Practice. Baltimore: Williams and Wilkins; 1993; 305-307.
11. von Segesser LK, Gyurech DD, Schilling JJ, Marquardt K, Turina MI. Can protamine be used during perfusion with heparin surface coated equipment? ASAIO J. 1993;39: M190-M194.